On trailing earnings, C is cheaper: AZN trades at a 26.92 P/E and C at 17.33.

Which has grown faster, AZN or C?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus C at 15.26%.

Does AZN or C pay a bigger dividend?

AZN yields 1.79% and C yields 1.72% based on trailing dividends and the latest price.

Is AZN or C more profitable?

AZN runs the higher net margin — AZN at 17.19% versus C at 9.34%.

AstraZeneca PLC (AZN) vs Citigroup Inc. (C)

AZN leads on 9 of 14 compared metrics, though C is the cheaper stock.

A side-by-side comparison of AstraZeneca PLC and Citigroup Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

$139.83Financial Services

Total return — AZN vs C

growth of $100 · last 30y

AZN +732.9%C +35.1%AZN compounded faster

Log scale — wide-divergence pair

AZN C

AZN vs C: by the numbers

•AZN is the larger company ($277.22B vs $238.49B market cap).
•C trades at the lower earnings multiple (17.33 vs 26.92 P/E).
•AZN converts more revenue to profit (17.19% vs 9.34% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 15.26% CAGR).
•AZN pays the higher dividend yield (1.79% vs 1.72%).

Which is better, AZN or C?

Metric tally: AZN 9 · C 5

It depends on what you're optimizing for:

ValueC(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeAZN(higher dividend yield)

QualityAZN(higher ROIC)

Metrics side by side

Valuation

Metric	AZN	C
P/E ratio	26.92	17.33●
Forward P/E	15.33	11.19●
P/S ratio	4.62	1.45●
P/B ratio	5.90	1.18●
PEG ratio	0.14●	0.75
EV / EBITDA	14.92	—
FCF yield	2.89%	—

Profitability

Metric	AZN	C
Gross margin	81.68%●	45.48%
Operating margin	23.69%●	12.79%
Net margin	17.19%●	9.34%
ROE	21.95%●	7.58%
ROIC	13.03%●	0.95%

Dividends

Metric	AZN	C
Dividend yield	1.79%●	1.72%
Payout ratio	48.48%	33.20%

Growth (annualized)

Metric	AZN	C
Revenue CAGR (5Y)	16.99%●	15.26%
EPS CAGR (5Y)	22.02%●	8.77%
FCF CAGR (5Y)	15.68%	—
Total return CAGR (5Y)	11.03%	16.79%●

Frequently asked

Which is better, AZN or C?: It depends on your goal. value: C (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: AZN (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 9 to 5.
Is AZN or C cheaper?: On trailing earnings, C is cheaper: AZN trades at a 26.92 P/E and C at 17.33.
Which has grown faster, AZN or C?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus C at 15.26%.
Does AZN or C pay a bigger dividend?: AZN yields 1.79% and C yields 1.72% based on trailing dividends and the latest price.
Is AZN or C more profitable?: AZN runs the higher net margin — AZN at 17.19% versus C at 9.34%.

Go deeper

Full AZN analysis Full C analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Citigroup P/E ratio AstraZeneca dividend yield Citigroup dividend yield AstraZeneca ROE Citigroup ROE AstraZeneca operating margin Citigroup operating margin AstraZeneca revenue growth Citigroup revenue growth AstraZeneca free cash flow Citigroup free cash flow

AstraZeneca & Citigroup appear in these rankings

Fastest Revenue Growth Stocks Best 10-Year Total Return Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.